OneSource Specialty Pharma's partners get Health Canada approval for generic Semaglutide injection
Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
Week-long Fire Safety Week 2026 campaign focuses on strengthening fire prevention, preparedness, audits, and emergency response across hospitals and healthcare facilities
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Workshop focused on strengthening sterile processing standards, infection prevention, and CSSD best practices in healthcare settings
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right
Subscribe To Our Newsletter & Stay Updated